Masimo Corporation (MASI)

Currency in USD
133.87
-3.13(-2.28%)
Closed·
133.870.00(0.00%)
·
MASI is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
133.59136.50
52 wk Range
131.47194.88
Key Statistics
Prev. Close
137
Open
135.96
Day's Range
133.59-136.5
52 wk Range
131.47-194.88
Volume
536.7K
Average Volume (3m)
765.74K
1-Year Change
-20.08%
Book Value / Share
14.91
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
MASI Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
183.75
Upside
+37.26%
Members' Sentiments
Bearish
Bullish
ProTips
Net income is expected to grow this year

Masimo Corporation News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell

Masimo Company Profile

Masimo Corporation develops, manufactures, and markets various patient monitoring technologies, and automation and connectivity solutions worldwide. The company offers masimo signal extraction technology (SET) pulse oximetry with measure-through motion and low perfusion pulse oximetry monitoring to address the primary limitations of conventional pulse oximetry; Masimo rainbow SET platform, including rainbow SET Pulse CO-Oximetry products that allows noninvasive monitoring of oxygen, carboxyhemoglobin, methemoglobin, hemoglobin, fractional arterial oxygen saturation, pleth variability index, rainbow pleth variability index, respiration rate from the pleth, and oxygen reserve index, as well as acoustic respiration monitoring, NomoLine capnography and gas monitoring, and regional oximetry. It also provides brain function and hemodynamic monitoring solutions; patient position and activity tracking, and neuromodulation technology solutions; and Masimo Hospital Automation platform, including hospital automation solutions, including Patient SafetyNet, SafetyNet, Replica, Iris, MyView, UniView, Uniview: 60, Masimo Sleep, Centroid, and Bridg; and nasal high-flow respiratory support therapy, neuromodulation technology, and telehealth solutions. In addition, the company provides its products through direct sales force, distributors, and original equipment manufacturers partners to hospitals, emergency medical service and home care providers, long-term care facilities, physician offices, veterinarians, and consumers; and home wellness products through e-commerce internet sites, such as masimopersonalhealth.com, amazon.com, and shopify.com. Masimo Corporation was incorporated in 1989 and is headquartered in Irvine, California.

Masimo Corporation Earnings Call Summary for Q3/2025

  • Masimo's Q3 2025 adjusted EPS of $1.32 exceeded forecasts by 10%, with revenue reaching $371.5 million, driving a 2.75% stock increase to $144.96.
  • Revenue grew 8% year-over-year with a 38% increase in adjusted EPS, while the company maintained strong margins with operating margin rising to 27.1%.
  • Strategic initiatives include an expanded Philips partnership, AI-enabled innovations, and completion of Sound United asset sale, strengthening Masimo's healthcare technology position.
  • The company returned $350 million to shareholders through stock repurchases and provided FY guidance of $1,510-$1,530 million in revenue with EPS of $5.40-$5.55.
  • CEO Katie Szyman expressed confidence in meeting 2025 goals, with further details expected at the December 3rd Investor Day.
Last Updated: 04/11/2025, 22:36
Read Full Transcript

Compare MASI to Peers and Sector

Metrics to compare
MASI
Peers
Sector
Relationship
P/E Ratio
−29.9x−3.0x−0.6x
PEG Ratio
0.04−0.630.00
Price/Book
8.9x3.9x2.6x
Price / LTM Sales
3.3x2.9x3.2x
Upside (Analyst Target)
33.2%74.8%41.8%
Fair Value Upside
Unlock21.8%5.1%Unlock

Analyst Ratings

6 Buy
3 Hold
0 Sell
Ratings:
9 analysts
Overall Consensus
Buy

Analysts 12-Month Price Target:

Average 183.75
(+37.26% Upside)
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate
Stifel
Buy180.00+34.46%-Maintain04/12/2025
Needham
Hold---Maintain04/12/2025
BTIG
Buy200.00+49.40%198.00Maintain04/12/2025
Needham
Hold---Maintain28/11/2025
Piper Sandler
Buy210.00+56.87%-Maintain25/11/2025

Earnings

Latest Release
Nov 04, 2025
EPS / Forecast
1.32 / 1.20
Revenue / Forecast
371.50M / 366.85M
EPS Revisions
Last 90 days

Masimo (MASI) Income Statement & Profits

People Also Watch

185.31
JKHY
-0.01%
17.21
ACI
-1.38%
63.25
LIVN
+0.32%
89.10
SSNC
+0.21%
68.08
PVH
-1.90%

FAQ

What Is the Masimo (MASI) Share Price Today?

The live Masimo share price today is 133.87

What Stock Exchange Does Masimo (MASI) Trade On?

Masimo is listed and trades on the Nasdaq Stock Exchange.

What Is the Ticker (Stock Symbol) for Masimo?

The stock symbol (also called a 'ticker') for Masimo is "MASI."

What Is the Current Masimo Market Cap?

As of today, Masimo market capitalisation is 7.19B.

What Is Masimo's (MASI) Earnings Per Share (TTM)?

The Masimo EPS is currently -4.45 (Trailing Twelve Months).

When Is the Next Masimo Earnings Date?

Masimo's next earnings report will be released on 03 Mar 2026.

Is MASI a Buy or Sell From a Technical Analyst Perspective?

Based on today's Masimo moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.

How Many Times Has Masimo Stock Split?

Masimo has split 0 times. (See the MASI stock split history page for full effective split date and price information.)

How Many Employees Does Masimo Have?

Masimo has 3600 employees.

What is the current trading status of Masimo (MASI)?

As of 24 Dec 2025, Masimo (MASI) is trading at a price of 133.87, with a previous close of 137.00. The stock has fluctuated within a day range of 133.59 to 136.50, while its 52-week range spans from 131.47 to 194.88.

What Is Masimo (MASI) Price Target According to Analysts?

The average 12-month price target for Masimo is USD183.75, with a high estimate of USD210 and a low estimate of USD162. 6 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Buy. The stock has an +37.26% Upside potential.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.